197 related articles for article (PubMed ID: 9862856)
21. Apoptotic behaviour of hepatic and extra-hepatic tumor cell lines differs after Fas stimulation.
Lamboley C; Bringuier AF; Feldmann G
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):13-28. PubMed ID: 10726968
[TBL] [Abstract][Full Text] [Related]
22. Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine.
Urayama S; Kawakami A; Nakashima T; Tsuboi M; Yamasaki S; Hida A; Ichinose Y; Nakamura H; Ejima E; Aoyagi T; Nakamura T; Migita K; Kawabe Y; Eguchi K
J Lab Clin Med; 2000 Sep; 136(3):181-93. PubMed ID: 10985496
[TBL] [Abstract][Full Text] [Related]
23. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
Toyozumi Y; Arima N; Izumaru S; Kato S; Morimatsu M; Nakashima T
Int J Oncol; 2004 Sep; 25(3):721-8. PubMed ID: 15289875
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
Okamura M; Hashimoto K; Shimada J; Sakagami H
Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
[TBL] [Abstract][Full Text] [Related]
25. Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines.
Bellarosa D; Ciucci A; Bullo A; Nardelli F; Manzini S; Maggi CA; Goso C
J Pharmacol Exp Ther; 2001 Feb; 296(2):276-83. PubMed ID: 11160608
[TBL] [Abstract][Full Text] [Related]
26. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of insulin-like growth factor binding proteins and growth modulation in hepatoma cells by retinoic acid.
Kim DG; Lee DY; Cho BH; You KR; Kim MY; Ahn DS
Hepatology; 1999 Apr; 29(4):1091-8. PubMed ID: 10094952
[TBL] [Abstract][Full Text] [Related]
28. Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway.
Zhang H; Ozaki I; Mizuta T; Matsuhashi S; Yoshimura T; Hisatomi A; Tadano J; Sakai T; Yamamoto K
Cancer; 2002 Aug; 95(4):896-906. PubMed ID: 12209735
[TBL] [Abstract][Full Text] [Related]
29. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells.
Kang YH; Lee KA; Ryu CJ; Lee HG; Lim JS; Park SN; Paik SG; Yoon DY
Cancer Lett; 2006 Jun; 237(1):33-44. PubMed ID: 16019139
[TBL] [Abstract][Full Text] [Related]
30. Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.
Perabo FG; Kamp S; Schmidt D; Lindner H; Steiner G; Mattes RH; Wirger A; Pegelow K; Albers P; Kohn EC; von Ruecker A; Mueller SC
Br J Cancer; 2001 May; 84(10):1330-8. PubMed ID: 11355943
[TBL] [Abstract][Full Text] [Related]
31. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
32. Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth control.
Gerharz CD; Ramp U; Déjosez M; Mahotka C; Czarnotta B; Bretschneider U; Lorenz I; Müller M; Krammer PH; Gabbert HE
Lab Invest; 1999 Dec; 79(12):1521-34. PubMed ID: 10616203
[TBL] [Abstract][Full Text] [Related]
33. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis.
Mori S; Murakami-Mori K; Jewett A; Nakamura S; Bonavida B
Cancer Res; 1996 Apr; 56(8):1874-9. PubMed ID: 8620507
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin-treated murine peritoneal macrophages induce apoptosis in L929 cells: role of Fas-Fas ligand and tumor necrosis factor-tumor necrosis factor receptor 1.
Chauhan P; Sodhi A; Tarang S
Anticancer Drugs; 2007 Feb; 18(2):187-96. PubMed ID: 17159605
[TBL] [Abstract][Full Text] [Related]
35. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
36. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis in HL60 leukemic cells by anticancer drugs in combination with anti-Fas monoclonal antibody.
Nakamura S; Takeshima M; Nakamura Y; Ohtake S; Matsuda T
Anticancer Res; 1997; 17(1A):173-9. PubMed ID: 9066648
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells.
Rebillard A; Jouan-Lanhouet S; Jouan E; Legembre P; Pizon M; Sergent O; Gilot D; Tekpli X; Lagadic-Gossmann D; Dimanche-Boitrel MT
Eur J Cancer; 2010 May; 46(8):1445-55. PubMed ID: 20202822
[TBL] [Abstract][Full Text] [Related]
39. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines.
Ng LT; Chiang LC; Lin YT; Lin CC
Am J Chin Med; 2006; 34(1):125-35. PubMed ID: 16437745
[TBL] [Abstract][Full Text] [Related]
40. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
Jiang L; Li JG; Lan L; Wang YM; Mao Q; You JP
Transplant Proc; 2010 Nov; 42(9):3773-8. PubMed ID: 21094855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
